https://wikimd.org/index.php?action=history&feed=atom&title=Cyclin_D3Cyclin D3 - Revision history2026-04-25T04:25:58ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Cyclin_D3&diff=6010466&oldid=prevPrab: CSV import2024-10-27T14:55:09Z<p>CSV import</p>
<p><b>New page</b></p><div>= Cyclin D3 =<br />
<br />
'''Cyclin D3''' is a member of the D-type cyclins, which are crucial regulators of the cell cycle. Cyclins are proteins that control the progression of cells through the cell cycle by activating [[cyclin-dependent kinases]] (CDKs). Cyclin D3, along with Cyclin D1 and Cyclin D2, plays a pivotal role in the transition from the G1 phase to the S phase of the cell cycle.<br />
<br />
== Structure and Function ==<br />
Cyclin D3 is encoded by the ''CCND3'' gene located on chromosome 6 in humans. The protein consists of a conserved cyclin box domain that is essential for its interaction with CDKs, particularly [[CDK4]] and [[CDK6]]. This interaction is necessary for the phosphorylation of the retinoblastoma protein (Rb), which leads to the release of E2F transcription factors and the subsequent transcription of genes required for S phase entry.<br />
<br />
== Role in Cell Cycle Regulation ==<br />
Cyclin D3, in complex with CDK4/6, is involved in the early G1 phase of the cell cycle. It is responsible for the phosphorylation of the Rb protein, which is a critical step in the regulation of the cell cycle. The activity of Cyclin D3 is regulated by various mitogenic signals, including growth factors and cytokines, which ensure that cell division occurs in response to external stimuli.<br />
<br />
== Clinical Significance ==<br />
Cyclin D3 has been implicated in various cancers due to its role in cell cycle regulation. Overexpression of Cyclin D3 can lead to uncontrolled cell proliferation, a hallmark of cancer. It has been studied in the context of [[lymphomas]], [[leukemias]], and [[breast cancer]].<br />
<br />
=== Lymphomas and Leukemias ===<br />
In certain types of lymphomas and leukemias, Cyclin D3 is overexpressed, contributing to the pathogenesis of these diseases. For example, in [[T-cell acute lymphoblastic leukemia]] (T-ALL), Cyclin D3 is often found to be upregulated, leading to increased cell proliferation.<br />
<br />
=== Breast Cancer ===<br />
Cyclin D3, along with Cyclin D1, has been studied in breast cancer. Its overexpression is associated with poor prognosis and resistance to certain therapies. Targeting the Cyclin D3/CDK4/6 axis is a potential therapeutic strategy in breast cancer treatment.<br />
<br />
== Research and Therapeutic Implications ==<br />
The development of CDK4/6 inhibitors, such as [[palbociclib]], has opened new avenues for targeting Cyclin D3 activity in cancer therapy. These inhibitors have shown promise in treating cancers with dysregulated Cyclin D3 activity by halting cell cycle progression and inducing cell cycle arrest.<br />
<br />
== Conclusion ==<br />
Cyclin D3 is a critical regulator of the cell cycle, and its dysregulation is associated with various malignancies. Understanding its role in cell cycle control and its implications in cancer can lead to the development of targeted therapies that improve patient outcomes.<br />
<br />
== References ==<br />
* Sherr, C. J., & Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. ''Genes & Development'', 13(12), 1501-1512.<br />
* Malumbres, M., & Barbacid, M. (2009). Cell cycle, CDKs and cancer: a changing paradigm. ''Nature Reviews Cancer'', 9(3), 153-166.<br />
<br />
[[Category:Cell cycle]]<br />
[[Category:Proteins]]<br />
[[Category:Oncology]]</div>Prab